首页|重型肝炎合并感染发生情况调查及相关因素分析

重型肝炎合并感染发生情况调查及相关因素分析

扫码查看
目的 探讨重型肝炎合并感染的发生情况及相关影响因素.方法 以2021年4月至2023年1月医院收治的219例重型肝炎患者为研究对象,根据是否合并感染将患者分为感染组(84例)和未感染组(135例).分析重型肝炎患者感染发生情况,比较两组性别、年龄、体重指数(BMI)、病程、侵入性操作、使用抗菌药物、白细胞、中性粒细胞、白蛋白、消化道出血、低钾血症、胆碱酯酶、胆固醇、肌酐、血糖、血清可溶性白细胞分化抗原CD14亚型(Presepsin)、血清可溶性肿瘤坏死因子相关凋亡诱导配体(sTRAIL)、血清白细胞介素-15(IL-15)、血清正五聚蛋白3(PTX3)、血清肝素结合蛋白(HBP).logistic多因素分析重型肝炎合并感染相关危险因素,分析血清指标对重型肝炎合并感染的预测价值.结果 219例重型肝炎患者中,合并感染者84例,感染率为38.36%.两组使用抗菌药物、血清Presepsin、sTRAIL、IL-15、PTX3、HBP水平比较,差异有统计学意义(P<0.05).血清Presepsin、sTRAIL、IL-15、PTX3、HBP水平为重型肝炎患者合并感染的危险因素(P<0.05),合理使用抗菌药物为重型肝炎患者合并感染的保护因素(P<0.05).血清Presepsin、sTRAIL、IL-15、PTX3、HBP联合预测重型肝炎合并感染的曲线下面积大于各单项指标(P<0.05).结论 重型肝炎患者感染发生风险较高,主要与使用抗菌药物及血清Presepsin、sTRAIL、IL-15、PTX3、HBP水平等因素有关,血清Presepsin、sTRAIL、1L-15、PTX3、HBP可作为早期筛查项目进行监测.
Investigation of Severe Hepatitis Co-infection and Analysis of Related Influencing Factors
Objective To investigate the incidence and related influencing factors of severe hepatitis co-infection.Methods A total of 219 patients with severe hepatitis admitted to Nanyang central Hospital from April 2021 to January 2023 were divided into infected group(84 cases)and uninfected group(135 cases)according to whether they were co-infected.To analyze the incidence of infection in patients with severe hepatitis.Gender,age,body mass index(BMI),course of disease,invasive procedure,use of antibiotics,leukocytes,neutrophils,albumin,gastrointestinal bleeding,hypokalemia,cholinesterase,cholesterol,creatinine,blood glucose,serum soluble leukocyte differentiation antigen CD14 subtype(Presepsin),and serum soluble tumor necrosis factor Apoptosis-inducing ligand(sTRAIL),serum interleukin-15(IL-15),serum pentamerin 3(PTX3),serum heparin binding protein(HBP)were compared between the two groups.Logistic multivariate analysis of the risk factors associated with severe hepatitis co-infection and the predictive value of serum indexes for severe hepatitis co-infection.Results Among 219 patients with severe hepatitis,84 were co-infected,the infection rate was 38.36%.There were significant differences in the levels of antibiotics,serum Presepsin,sTRAIL,IL-15,PTX3 and HBP between the two groups(P<0.05).Serum Presepsin,sTRAIL,IL-15,PTX3 and HBP levels were risk factors for severe hepatitis co-infection(P<0.05),and rational use of antibiotics was protective factor for severe hepatitis co-infection(P<0.05).The area under curve of serum presepsin,sTRAIL,IL-15,PTX3 and HBP combined to predict severe hepatitis co-infection was higher than that of each single index(P<0.05).Conclusion Patients with severe hepatitis have a higher risk of infection,which is mainly related to the use of antibiotics and the levels of serum Presepsin,sTRAIL,IL-15,PTX3,HBP and other factors.Serum Presepsin,sTRAIL,IL-15,PTX3,HBP can be used as an early screening program for monitoring.

severe hepatitisinfectioninfluencing factors

孙孟、王凤超、贾静、刘义锋、王改存、俞致贤

展开 >

南阳市中心医院感染性疾病科,河南南阳 471003

南阳市中心医院心血管内科,河南南阳 471003

南阳市中心医院神经内科,河南南阳 471003

重型肝炎 感染 影响因素

2024

河南医学研究
河南省医学科学院

河南医学研究

影响因子:0.979
ISSN:1004-437X
年,卷(期):2024.33(2)
  • 17